LONDON — If you have a swollen jaw or sore throat, you may want to consider taking omepazole, a prescription medicine that reduces bloating and other side effects of drugs that reduce gas.
Omeprazoles are the third-most commonly prescribed drug in the U.K. after ibuprofen and acetaminophen, according to the latest figures from the Office for National Statistics.
Oxford University researchers say they are studying the effectiveness of omeproszole and are considering a clinical trial.
They say the drug, which has not been approved by the U, is unlikely to have an impact on gas levels, and that a trial is warranted.
“Omiprazole has not shown a statistically significant difference between patients taking it in combination with ibuprophen or acetaminol, and patients taking them alone,” the researchers wrote.
“It is, however, likely to have a greater effect on gum swelling and acid production than ibuprazole and acetazolam combined.”
Ompproszoles work by blocking an enzyme known as cyclooxygenase-2, which is the cause of gas.
The drug, when taken in high doses, increases the body’s production of the enzyme.
However, the researchers say, there is not enough evidence to say it is safe for long-term use.
There is no evidence to show that omeproszes reduce gas or gum swelling in people who do not take the medication, but it does reduce gas and gum swelling among people who take the drug in high enough doses.
If patients don’t stop omiproszolle for more than a few days, their gums become inflamed and become more sensitive to acid, which can lead to swelling and inflammation.
Omproszols also have side effects including increased blood pressure, high cholesterol, and kidney problems.
Many people also report gastrointestinal side effects such as diarrhea, nausea, and constipation.
The side effects are most common in older adults, those with kidney disease, those who take high doses of omiprazoles, and people with chronic disease, such as cancer.
The researchers say there is no information about long-lasting effects in people taking omoproszolyls, but the drug should be prescribed in higher doses, which are not available in the UK.
For more news from the world of health care, click here